UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mediators of racial disparity in the use of prostate MRI

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6554-6554

2021

Volltextzugriff (PDF)

Demographic and clinical factors associated with cardiovascular events in elderly long-term survivors of breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24105-e24105

2023

Volltextzugriff (PDF)

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.415-415

2018

Volltextzugriff (PDF)

Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e24050-e24050

2020

Volltextzugriff (PDF)

Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.610-610

2023

Volltextzugriff (PDF)

Personalized risk assessment of new onset depression in long-term cancer survivors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13798-e13798

2024

Volltextzugriff (PDF)

Treatment exposure-based risk-stratification for care of survivors of childhood cancer: A report from the Childhood Cancer Survivor Study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10056-10056

2022

Volltextzugriff (PDF)

Nationwide utilization and costs of targeted anti-cancer drugs for elderly patients with solid tumors in the United States, 2004-2015

Journal of clinical oncology, 2018-10, Vol.36 (30_suppl), p.23-23

2018

Volltextzugriff (PDF)

Association between mammographic screening history and stage at diagnosis among women with screen-detected breast cancer

JCO oncology practice, 2024-10, Vol.20 (10_suppl), p.145-145

2024

Volltextzugriff (PDF)

Treatment patterns and health care resource use of patients with metastatic breast cancer with HER2-low expression: A cancer registry-linked insurance claims study

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.399-399

2022

Volltextzugriff (PDF)

Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.280-280

2021

Volltextzugriff (PDF)

Patterns and predictors of oral anticancer agent utilization in diverse metastatic renal cell carcinoma patients

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.279-279

2021

Volltextzugriff (PDF)

Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.106-106

2020

Volltextzugriff (PDF)

Factors associated with the quality of end-of-life care for patients with metastatic renal cell carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.300-300

2022

Volltextzugriff (PDF)

Trends in new and persistent opioid use in older adults with cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1592-1592

2023

Volltextzugriff (PDF)

Patient- and provider-level predictors of mortality among patients with metastatic renal cell carcinoma receiving oral anticancer agents

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.116-116

2021

Volltextzugriff (PDF)

Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.87-87

2021

Volltextzugriff (PDF)

Mutation-specific costs of advanced non-small cell lung cancer treatment

JCO oncology practice, 2023-11, Vol.19 (11_suppl), p.14-14

2023

Volltextzugriff (PDF)

Chemotherapy costs associated with receipt of the adoption of oncotype DX in early-stage breast cancer within the SEER-Medicare population

Journal of clinical oncology, 2016-03, Vol.34 (7_suppl), p.32-32

2016

Volltextzugriff (PDF)

Nationwide utilization of cardiac imaging in patients undergoing cardiotoxic chemotherapy

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6592-6592

2015

Volltextzugriff (PDF)

Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT)

Journal of clinical oncology, 2018-03, Vol.36 (7_suppl), p.127-127

2018

Volltextzugriff (PDF)

Association between Oncotype DX and receipt of chemotherapy in early-stage breast cancer within the Medicare population from 2004 to 2007

Journal of clinical oncology, 2014-10, Vol.32 (30_suppl), p.309-309

2014

Volltextzugriff (PDF)

Total and treatment-related costs of care associated with in patients with metastatic renal cell carcinoma receiving targeted or immune therapy

JCO oncology practice, 2023-11, Vol.19 (11_suppl), p.28-28

2023

Volltextzugriff (PDF)

Association between CT utilization and radiation therapy at the end of life (EOL) in elderly breast and prostate cancer patients

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6529-6529

2014

Volltextzugriff (PDF)

Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6508-6508

2014

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(37)
Dissertationen
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mediators of racial disparity in the use of prostate MRI

Demographic and clinical factors associated with cardiovascular events in elderly long-term survivors of breast cancer

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma

Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL)

Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma

Personalized risk assessment of new onset depression in long-term cancer survivors

Treatment exposure-based risk-stratification for care of survivors of childhood cancer: A report from the Childhood Cancer Survivor Study

Nationwide utilization and costs of targeted anti-cancer drugs for elderly patients with solid tumors in the United States, 2004-2015

Association between mammographic screening history and stage at diagnosis among women with screen-detected breast cancer

Treatment patterns and health care resource use of patients with metastatic breast cancer with HER2-low expression: A cancer registry-linked insurance claims study

Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC)

Patterns and predictors of oral anticancer agent utilization in diverse metastatic renal cell carcinoma patients

Disparities in utilization of oral anticancer agents and related costs in elderly patients with metastatic renal cell carcinoma in the United States

Factors associated with the quality of end-of-life care for patients with metastatic renal cell carcinoma

Trends in new and persistent opioid use in older adults with cancer

Patient- and provider-level predictors of mortality among patients with metastatic renal cell carcinoma receiving oral anticancer agents

Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

Mutation-specific costs of advanced non-small cell lung cancer treatment

Chemotherapy costs associated with receipt of the adoption of oncotype DX in early-stage breast cancer within the SEER-Medicare population

Nationwide utilization of cardiac imaging in patients undergoing cardiotoxic chemotherapy

Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT)

Association between Oncotype DX and receipt of chemotherapy in early-stage breast cancer within the Medicare population from 2004 to 2007

Total and treatment-related costs of care associated with in patients with metastatic renal cell carcinoma receiving targeted or immune therapy

Association between CT utilization and radiation therapy at the end of life (EOL) in elderly breast and prostate cancer patients

Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007

Suchergebnisse filtern